Sk Bioscience
- All
- News
-
GlaxoSmithKline, SK Bioscience Start Final Trial Of COVID-19 Jab
British drugs giant GlaxoSmithKline and South Korean peer SK bioscience have begun final stage trials of a Covid-19 jab after positive early results, they announced Tuesday.
-
Bill Gates Says South Korean Firm Could Make 200 Million Vaccines by June
SK Bioscience, the South Korean pharmaceutical company backed by Bill Gates, may be capable of producing 200 million coronavirus vaccine kits by next June, the Microsoft Corp. co-founder said in a letter to South Korean President Moon Jae-in.
-
GlaxoSmithKline, SK Bioscience Start Final Trial Of COVID-19 Jab
British drugs giant GlaxoSmithKline and South Korean peer SK bioscience have begun final stage trials of a Covid-19 jab after positive early results, they announced Tuesday.
-
Bill Gates Says South Korean Firm Could Make 200 Million Vaccines by June
SK Bioscience, the South Korean pharmaceutical company backed by Bill Gates, may be capable of producing 200 million coronavirus vaccine kits by next June, the Microsoft Corp. co-founder said in a letter to South Korean President Moon Jae-in.
